We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
On Feb 22, we issued an updated research report on Integer Holdings Corporation (ITGR - Free Report) . A solid view for 2019 is working in favor of the company despite stiff rivalry in the MedTech space.
The stock currently carries a Zacks Rank #3 (Hold).
What’s Favoring the Stock?
Along with a solid fourth-quarter show, Integer Holdings issued a strong 2019 view.
Notably, adjusted earnings per share are expected within $4.05 to $4.25, indicating a rise of 7-12% from the previous year. Integer Holdings expects earnings per share in the $2.77 to $2.97 band on a reported basis, mirroring 7-12% growth year over year.
For 2019, Integer Holdings expects revenues between $1.26 billion and $1.28 billion, reflecting year-over-year growth of 4-5%. On an adjusted basis, the company expects revenues in the same band, showing growth of 4-6% from the previous year. Adjusted income from operations is anticipated between $141 million and $275 million, calling for a year-over-year rise of 8-13%.
Additionally, Integer Holdings has a stable footing in the cardiac, neuromodulation, orthopedics, vascular and advanced surgical markets.
In the recently-reported fourth quarter, Integer Holdings focused its sales efforts on increasing market penetration in the higher growth Cardio & Vascular, Neuromodulation and Non-Medical Electrochem markets. The company is also making strategic initiatives to maintain its leadership position in the cardiac rhythm management market.
Shares Up
Over the past year, shares of Integer Holdings have rallied 70% compared with the S&P 500 index’s 0.5% gain.
Deterrents
Integer Holdings earns a major portion of revenues from cardiac, neuromodulation, orthopedics, vascular, advanced surgical and power solutions markets. The company faces stiff competition in the MedTech space from players like Medtronic (MDT - Free Report) , Boston Scientific, Stryker (SYK - Free Report) , Smith & Nephew and ConvaTec.
Key Pick
A better-ranked stock from the Medical Instruments space is Wright Medical Group N.V. .
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Image: Bigstock
Integer Holdings' (ITGR) 2019 View Strong Despite Rivalry
Click here to see these breakthrough stocks now >>